The British journal of surgery
-
Transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) awaiting liver transplantation is widespread, although evidence that it improves outcomes is lacking and there exist concerns about morbidity. The impact of TACE on outcomes after transplantation was evaluated in this study. ⋯ TACE delivered to patients with HCC before liver transplant did not affect complications, patient death or graft failure after transplantation.